Sandy Spring Bank’s GenMark Diagnostics, Inc GNMK Stock Holding History

Sandy Spring Bank’s Portfolio GNMK Stock Details GNMK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-400	Closed	-$6K	–	1070
2020 Q4	$6K	Hold	400	–	–	﹤0.01%	818
2020 Q3	$6K	Hold	400	–	–	﹤0.01%	746
2020 Q2	$6K	Hold	400	–	–	﹤0.01%	760
2020 Q1	$2K	Hold	400	–	–	﹤0.01%	845
2019 Q4	$2K	Hold	400	–	–	﹤0.01%	812
2019 Q3	$2K	Hold	400	–	–	﹤0.01%	821
2019 Q2	$3K	Hold	400	–	–	﹤0.01%	804
2019 Q1	$3K	Hold	400	–	–	﹤0.01%	752
2018 Q4	$2K	Hold	400	–	–	﹤0.01%	755
2018 Q3	$3K	Hold	400	–	–	﹤0.01%	745
2018 Q2	$3K	Hold	400	–	–	﹤0.01%	736
2018 Q1	$2K	Hold	400	–	–	﹤0.01%	806
2017 Q4	$2K	Hold	400	–	–	﹤0.01%	813
2017 Q3	$4K	Hold	400	–	–	﹤0.01%	759
2017 Q2	$5K	Buy	+400	New	+$5.11K	﹤0.01%	766

Other funds holding GNMK

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Magnetar Financial Evanston, Illinois $9.84B AUM 190.64% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Versor Investments New York $40.8M AUM 93.59% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Sandy Spring Bank's GNMK Position: Q1 2021 in Review

Sandy Spring Bank sold out of GenMark Diagnostics, Inc (GNMK) in Q1 2021, closing a stake of 400 shares — an estimated $6K sold.

Sandy Spring Bank first reported a position in GNMK in Q2 2017 and held it in 15 quarters. The position peaked at $6K in Q4 2020. 164 funds tracked by Wall St. Rank hold GNMK as of Q1 2021.

Sandy Spring Bank reported no remaining GenMark Diagnostics, Inc position as of Q1 2021 after selling out during the quarter.
Sandy Spring Bank sold 400 GenMark Diagnostics, Inc shares in Q1 2021, an estimated $6K.
Sandy Spring Bank first reported a position in GenMark Diagnostics, Inc in Q2 2017 and held it in 15 quarters.
Sandy Spring Bank's GenMark Diagnostics, Inc position peaked at $6K in Q4 2020.
164 funds tracked by Wall St. Rank held GenMark Diagnostics, Inc as of Q1 2021.

Based on Sandy Spring Bank's 13F filing for Q1 2021, filed 3 May 2021.